Veterinary Vaccines Market to Reach $4.5 Billion by 2010, According to New Report by Global Industry Analysts, Inc.

Share Article

Veterinary Vaccines, a critical segment of the animal healthcare industry, is largely driven by technological advancements coupled with development of new vaccines. World market for Veterinary Vaccines market is projected to reach US$4.5 billion by 2010.

Veterinary Vaccines: A Global Strategic Business Report

Regardless of the adverse affects in various regions, pertaining to various market conditions both in companion animal segment and livestock segment, the veterinary vaccine sector has shown a steady growth in recent years. The credibility goes to progression made in biotechnology research. The technology contributed tremendously towards the enhancement of innovative vaccines that enabled combating various diseases. New product developments, rising longevity of pet population, advent of pet insurance, and the rising significance of pest and disease control in animals is expected to boost the market for companion animal vaccines. Further, rising demand for parasiticides, and systemic agents bodes well for the veterinary vaccines market.

United States and Europe collectively capture more than 60% of the worldwide Veterinary Vaccines market as stated by Global Industry Analysts, Inc. Among the segments analyzed Livestock vaccines market represents the largest accounting for a lion's share of about 63% in 2006. Revenues from porcine vaccines market are primed to cross the US$1 billion mark by 2010. United States companion animal vaccines market is projected to expand to US$410 million by 2010. Europe is a major market for veterinary vaccines and medicines across the globe. France, Germany and United Kingdom account for over 40% of the veterinary vaccine sales in Europe.

Leading players profiled in the report include AVANT Immunotherapeutics, Bayer HealthCare AG, Fort Dodge Animal Health, Heska Corporation, Imugene Limited, Intervet International B.V., Merial Animal Health Ltd., Pfizer, Inc., Protein Sciences Corporation, Schering-Plough, and Virbac Corporation

"Veterinary Vaccines: A Global Strategic Business Report" from Global Industry Analysts, Inc. provides a comprehensive review of market trends, drivers, challenges, product profile, competition, regulatory environment, mergers and acquisitions and other strategic industry activity. The new analysis reviews product innovations/introductions, and recent strategic corporate activity of major market participants across various product categories. Latent demand patterns are quantified across all geographic markets. Analysis is presented for established/emerging geographic markets such as United States, Japan, France, Germany, the UK, Italy, Spain, Asia, Latin America and the Middle East.

For more details of this research report please visit http://www.strategyr.com/MCP-1129.asp

About Global Industry Analysts, Inc.:
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Web Site http://www.StrategyR.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website